Proto Labs(US:PRLB)2026-02-06 14:32Financial Data and Key Metrics Changes - Fourth quarter revenue reached a record $136.5 million, up 11% year-over-year in constant currencies, marking the first sequential revenue growth from Q3 to Q4 since 2017 [18] - Full-year revenue for 2025 was a record $533.1 million, up 5.7% in constant currencies [20] - Non-GAAP gross margin for the fourth quarter was 44.8%, an increase of 140 basis points year-over-year [19] - Non-GAAP earnings per share for the fourth quarter were $0.44, up $0.06 year-over-year [19] Business Line Data and Key Metrics Changes - CNC revenue in the U.S. grew 35% in the fourth quarter and 16.7% year-over-year for 2025, driven by strong demand in drones, satellites, and rockets [18][20] - Injection molding revenue declined 1.9% in 2025, impacted by weakness in medical device and lower prototyping demand [20] - 3D printing revenue declined 4.7% year-over-year, although metal 3D printing showed strength with double-digit growth in DMLS revenue [21] Market Data and Key Metrics Changes - U.S. revenue grew 9.1% year-over-year, while European revenue declined 7% in constant currencies [20] - Fourth quarter revenue in the U.S. grew 15.9% year-over-year, while Europe experienced an 8.1% decline in constant currencies [18] Company Strategy and Development Direction - The company aims to serve customers across the entire life cycle of a part, from prototype through production, reinforcing its position as a leading provider of prototype parts [7][8] - Four strategic pillars include Elevate Customer Experience, Accelerate Innovation, Expand Production, and Drive Operational Efficiency [8][11] - The establishment of a Global Capability Center in India aims to enhance innovation and digital capabilities [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position to leverage growth in innovation-led markets such as aerospace, defense, and medical [32][44] - 2026 is expected to be a year of transformation and growth, with a focus on execution and operational improvements [11][24] - The company anticipates full-year 2026 revenue growth of 6%-8% [24] Other Important Information - The company generated $74.5 million in cash from operations in 2025, leading the digital manufacturing industry in cash generation [23] - The company has zero debt and $142.4 million in cash and investments on its balance sheet as of December 31, 2025 [23] Q&A Session Summary Question: Insights on Q4 performance and sequential growth - Management noted that Q4 saw good order volumes driven by customer engagement, but January started with a more normalized order rate [29][30] Question: Details on end markets and applications - Management confirmed strong growth in innovation-led markets, positioning the company well to serve these sectors [32] Question: Near-term versus long-term results from strategic initiatives - Management indicated that the current year is focused on transformation, with acceleration expected in future years [34] Question: Unique developers and revenue per contact - Management emphasized a focus on increasing revenue per contact, with a 23% increase noted in Q4 [41] Question: Injection molding business visibility - Management acknowledged the decline in prototyping but highlighted efforts to pivot towards production, especially in the medical sector [52] Question: India Global Capability Center focus - The center aims to leverage India's technical talent to support global business and innovation initiatives [56]